Video: Investors cheer Valeant board change 0 10.03.2016 01:06 The Globe and Mail Controversial drug company Valeant Pharmaceuticals, which has been under fire for drug-pricing practices, has added new board members as part of an effort to reassure investors. Bobbi Rebell reports. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
